Professor, Neurology, University of Alabama School of Medicine
Neurology
Dr. David S. Geldmacher, MD
|
|
Give Review
Dr. David S. Geldmacher is an expert in the field of Neurology. He went to medical school at State University of New York Upstate Medical University. He over the years received 1 awards: "Regional Top Doctor". David Geldmacher is a published doctor and has 59 publications published. The lastest was: 'Clock drawing test in very mild Alzheimer's disease.' He accepts all Medicare patients.
Publications
- Qualitative assessment of self-identity in people with advanced Dementia.
- Latent information in fluency lists predicts functional decline in persons at risk for Alzheimer Disease.
- Implications of early treatment among Medicaid patients with Alzheimer's Disease.
- Pre-Diagnosis Excess Acute Care Costs in Alzheimer's Patients among a US Medicaid Population.
- Parkinson Disease: research update and clinical management.
- Family quality of life in Dementia: a qualitative approach to family-identified care priorities.
- A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer Disease.
- Alzheimer Disease prevention: focus on cardiovascular risk, not amyloid?
- MR tractography depicting damage to the arcuate fasciculus in a patient with conduction aphasia.
- Treatment guidelines for Alzheimer's Disease: redefining perceptions in primary care.
- Conduction aphasia as a function of the dominant posterior perisylvian cortex. Report of two cases.
- The cost benefit to health plans of pharmacotherapy for Alzheimer's Disease.
- Dementia with Lewy bodies: diagnosis and clinical approach.
- Differential diagnosis of Dementia syndromes.
- Interdisciplinary approaches to Alzheimer's Disease management.
- Alzheimer's Disease and dementia.
- Long-Term Cholinesterase Inhibitor Therapy for Alzheimer's Disease: Practical Considerations for the Primary Care Physician.
- Visuospatial dysfunction in the neurodegenerative Diseases.
- Donepezil is associated with delayed nursing home placement in patients with Alzheimer's Disease.
- Alzheimer's Disease: current pharmacotherapy in the context of patient and family needs.
- Development of a scale to predict decline in patients with mild Alzheimer's Disease.
- Optimizing coding and reimbursement to improve management of Alzheimer's Disease and related dementias.
- Cost-effective recognition and diagnosis of Dementia.
- Practical Diagnosis and Management of Dementia Due to Alzheimer's Disease in the Primary Care Setting: An Evidence-Based Approach.
- Family composition and expressions of family-focused care needs at an academic memory Disorders clinic.
- Cost-effectiveness of drug therapies for Alzheimer''s Disease: A brief review.
- Donepezil in vascular Dementia: a viewpoint by David S. Geldmacher.
- Efficacy and tolerability of donepezil in vascular Dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
- Donepezil (Aricept) for treatment of Alzheimer''s Disease and other dementing conditions.
- Objective psychometric tests in clinical trials of Dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
- Nonoptic aphasia: aphasia with preserved confrontation naming in Alzheimer's Disease.
- Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. Th...
- Apathy in Alzheimer's Disease.
- DNA replication precedes neuronal cell death in Alzheimer's Disease.
- Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer Disease.
- Conflicting priorities in Alzheimer's care, primary care, and managed care: who pays the price?
- Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons.
- Spatial aspects of letter cancellation performance in Arabic readers.
- Three-dimensional neglect phenomena following right anterior choroidal Artery infarction.
- Age effects on random-array letter cancellation tests.
- Clock drawing test in very mild Alzheimer's Disease.
- Stimulus characteristics determine processing approach on random array letter-cancellation tasks.
- Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's Disease brain.
- The effect of character and array type on visual spatial search quality following traumatic Brain injury.
- Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs.
- Hallucinations.
- Differential diagnosis of Alzheimer's Disease.
- Enhancing recovery from ischemic Stroke.
- Effect of stimulus number, target-to-distractor ratio, and motor speed on visual spatial search quality following traumatic Brain injury.
- Effects of stimulus number and target-to-distractor ratio on the performance of random array letter cancellation tasks.
- Evaluation of Dementia.
- Fluoxetine in Dementia of the Alzheimer's type: prominent adverse effects and failure to improve cognition.
- Pharmacotherapy for Alzheimer's Disease.
- Visual field influence on radial line bisection.
- Ethical issues in Dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
- Activities of daily living as an outcome measure in clinical trials of Dementia drugs. Position paper from the International Working Group on Harmonization of Dementia...
- Donepezil (Aricept) therapy for Alzheimer's Disease.
- Realistic expectations for treatment success in Alzheimer''s Disease.
Schools
SUNY Upstate Medical University Syracuse
Mt Sinai Med Center
Case West Res
University Fla
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Nerve Block, Somatic
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Case Western Reserve University - University Hospitals -
Mount Sinai Medical Center -
State University of New York Upstate Medical University
Hospital
-
University of Alabama Hospital
Drug Facts
| NPI NUMBER | 1174692701 | |
| NPPES Provider LastName | GELDMACHER | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 352332110 | |
| NPPES Provider State | AL | |
| Specialty Description | Neurology | |
| Total Claim Count | 1497.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174692701 |
| Last Name Of The Provider | GELDMACHER |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Victor W. Sung, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul R. Atchison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Talene A. Yacoubian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Liang Lu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marla B. Morgan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harold F. Thomas, MD |
|
|
Dr. Gregory L. James, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ayaz M. Khawaja, MD |
|
|
Dr. Drew R. Uhrig, MD |
|
|
Dr. Shumaila Sultan, MD
This Doctor is OpenDoctor Recommended.
|